Lunai Bioworks (LNAI) Treasury Shares (2019 - 2025)

Lunai Bioworks (LNAI) recorded quarterly Treasury Shares of $467290.0 in Q2 2025, up 9245.8% quarter-over-quarter from $5000.0 in Q4 2021.

Lunai Bioworks (LNAI) Treasury Shares (2019 - 2025) Analysis & Trends

Lunai Bioworks' Treasury Shares history runs 4 years deep, the most recent figure standing at $467290.0 for Q2 2025.

In Q2 2025, Treasury Shares changed N/A year-over-year to $467290.0; the TTM figure through Jun 2025 stood at $467290.0 (changed N/A YoY), while the FY2025 annual figure was $467290.0, changed N/A from the prior year.
Treasury Shares was $467290.0 for Q2 2025 at Lunai Bioworks, up from $5000.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $467290.0 in Q2 2025 to a low of $5000.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Lunai Bioworks	95.85 Mn	92.70 Mn	20,942.00	-

Download Data